In vitro cytotoxicity of carbazole derivatives. V. 9-Halogeno-substituted 5,11-dimethyl-6H-pyrido[3,2-b]carbazoles

European Journal of Medicinal Chemistry

Volumn 32, Issue 2, 1997, Pages 113-122

  Moinet Hedin, V ^a,b   Tabka, T ^c   Sichel, F ^a,b   Gauduchon, P ^a,b   Le Talaer J Y ^a,b   Saturnino, C ^b   Letois, B ^b   Lancelot, J C ^b   Robba, M ^b  

^a CENTRE FRANÇOIS BACLESSE   (France)

^b UNIVERSITÉ DE CAEN   (France)

^c UNIVERSITY OF MONASTIR   (Tunisia)

Author keywords

Clonogenic assay; Cytotoxicity; Leukemia L1210; Pyrido 3,2 b carbazole

Indexed keywords

ANTINEOPLASTIC AGENT; CARBAZOLE DERIVATIVE; ELLIPTICINE; ELLIPTICINE DERIVATIVE;

ANIMAL CELL; ARTICLE; CLONOGENIC ASSAY; CONTROLLED STUDY; CYTOTOXICITY; DRUG SYNTHESIS; IN VITRO STUDY; LEUKEMIA L 1210; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; STRUCTURE ACTIVITY RELATION;

EID: 0031051343     PISSN: 02235234     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0223-5234(97)87537-X     Document Type: Article

References (16)

1. 1 Juret P, Heron JF, Couette JE, Delozier I, Le Talaer JY (1982) Cancer Treat Rep 66, 1916-1919
2. 2 Mucci-Lorusso P, Polin L, Biernot LA, Valeriote FA, Corbett TH (1990) Invest New Drugs 8, 253-261
3. 3 Balosso J, Giocanti N, Favaudon V (1991) Cancer Res 51, 3204-3211
4. 4 Moinet-Hedin V, Tabka T, Gauduchon P et al (1993) Eur J Med Chem 28, 721-726
5. 5 Cranwell PA, Saxton JE (1962) J Chem Soc 3482-3495
6. 6 Dalton LK, Demerac S, Elmes BC, Loder JW, Swan JM, Teitei T (1967) Austr J Chem 20, 2715-2720
7. 7 Dalton LK, Teitei T (1968) Austr J Chem 21, 2053-2060
8. es Rencontres internationales de chimie thérapeutique, Clermont-Ferrand
9. 9 Tabka T, Letois B, Lancelot JC et al (1989) Eur J Med Chem 24, 605-610
10. 10 Viossat B, Nguyen-huy D, Lancelot JC, Benazeth S, Rault S, Robba M (1992) Chem Pharm Bull 35, 1724-1733
11. 11 Nguyen-huy D, Viossat B, Lancelot JC, Robba M (1984) Acta Crystallogr Sect C 40. 1602-1608
12. 12 Robba M, Lancelot JC, Rault S, Gauduchon P, Le Talaer JY (1990) French Patent, RCI, 617/MR/CD, 90 09 688
13. 13 Paoletti C, Cros S, Dat-Xuong N. Lecointe P, Moisand A (1979) Chem Biol Interact 25, 45-58
14. 14 Acton EM, Narayanan VL, Risbood PA, Shoemaker RH, Vistica DT, Boyd MR (1994) J Med Chem 37, 2185-2189
15. 15 Shoemaker RH, Balaschak RS, Alexander RS, Boyd MR (1994) Proc Am Assoc Cancer Res 35, 399
16. 16 Lancelot JC, Rault S, Robba M, Nguyen-huy D (1987) Chem Pharm Bull 35, 425-433